Cargando…

The Fate of Porous Hydroxyapatite Granules Used in Facial Skeletal Augmentation

Facial appearance is largely determined by the morphology of the underlying skeleton. Hydroxyapatite is one of several materials available to enhance projection of the facial skeleton. This study evaluated the long-term maintenance of augmented bony projection when porous hydroxyapatite granules are...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendelson, Bryan C., Jacobson, Steve R., Lavoipierre, Alain M., Huggins, Richard J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906722/
https://www.ncbi.nlm.nih.gov/pubmed/20186415
http://dx.doi.org/10.1007/s00266-010-9473-2
_version_ 1782184046083702784
author Mendelson, Bryan C.
Jacobson, Steve R.
Lavoipierre, Alain M.
Huggins, Richard J.
author_facet Mendelson, Bryan C.
Jacobson, Steve R.
Lavoipierre, Alain M.
Huggins, Richard J.
author_sort Mendelson, Bryan C.
collection PubMed
description Facial appearance is largely determined by the morphology of the underlying skeleton. Hydroxyapatite is one of several materials available to enhance projection of the facial skeleton. This study evaluated the long-term maintenance of augmented bony projection when porous hydroxyapatite granules are used on the facial skeleton. Ten female patients aged 28–58 years were studied following aesthetic augmentation of the facial skeleton at 24 sites using porous hydroxyapatite granules. Postoperative CT scans at 3 months served as the baseline measurement and compared with scans taken at 1 and 2 years, with the thickness of the hydroxyapatite measured in axial and coronal planes. Thickness of original bone plus overlay of hydroxyapatite, thickness of the overlying soft tissue, and the overall projection (bone plus soft tissue) were recorded. It was found that 99.7% of the hydroxyapatite was maintained at 2 years, with no statistical difference (t test) from the baseline measurement. The overall projection (bony and soft tissue) was maintained as there was no evidence of native bone resorption or soft tissue atrophy. Radiographic results confirmed that the use of porous hydroxyapatite granules for enhancement of the facial skeleton is not only a predictable procedure, but maintains full bony projection at 2 years.
format Text
id pubmed-2906722
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-29067222010-08-06 The Fate of Porous Hydroxyapatite Granules Used in Facial Skeletal Augmentation Mendelson, Bryan C. Jacobson, Steve R. Lavoipierre, Alain M. Huggins, Richard J. Aesthetic Plast Surg Original Article Facial appearance is largely determined by the morphology of the underlying skeleton. Hydroxyapatite is one of several materials available to enhance projection of the facial skeleton. This study evaluated the long-term maintenance of augmented bony projection when porous hydroxyapatite granules are used on the facial skeleton. Ten female patients aged 28–58 years were studied following aesthetic augmentation of the facial skeleton at 24 sites using porous hydroxyapatite granules. Postoperative CT scans at 3 months served as the baseline measurement and compared with scans taken at 1 and 2 years, with the thickness of the hydroxyapatite measured in axial and coronal planes. Thickness of original bone plus overlay of hydroxyapatite, thickness of the overlying soft tissue, and the overall projection (bone plus soft tissue) were recorded. It was found that 99.7% of the hydroxyapatite was maintained at 2 years, with no statistical difference (t test) from the baseline measurement. The overall projection (bony and soft tissue) was maintained as there was no evidence of native bone resorption or soft tissue atrophy. Radiographic results confirmed that the use of porous hydroxyapatite granules for enhancement of the facial skeleton is not only a predictable procedure, but maintains full bony projection at 2 years. Springer-Verlag 2010-02-26 2010 /pmc/articles/PMC2906722/ /pubmed/20186415 http://dx.doi.org/10.1007/s00266-010-9473-2 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Mendelson, Bryan C.
Jacobson, Steve R.
Lavoipierre, Alain M.
Huggins, Richard J.
The Fate of Porous Hydroxyapatite Granules Used in Facial Skeletal Augmentation
title The Fate of Porous Hydroxyapatite Granules Used in Facial Skeletal Augmentation
title_full The Fate of Porous Hydroxyapatite Granules Used in Facial Skeletal Augmentation
title_fullStr The Fate of Porous Hydroxyapatite Granules Used in Facial Skeletal Augmentation
title_full_unstemmed The Fate of Porous Hydroxyapatite Granules Used in Facial Skeletal Augmentation
title_short The Fate of Porous Hydroxyapatite Granules Used in Facial Skeletal Augmentation
title_sort fate of porous hydroxyapatite granules used in facial skeletal augmentation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906722/
https://www.ncbi.nlm.nih.gov/pubmed/20186415
http://dx.doi.org/10.1007/s00266-010-9473-2
work_keys_str_mv AT mendelsonbryanc thefateofporoushydroxyapatitegranulesusedinfacialskeletalaugmentation
AT jacobsonstever thefateofporoushydroxyapatitegranulesusedinfacialskeletalaugmentation
AT lavoipierrealainm thefateofporoushydroxyapatitegranulesusedinfacialskeletalaugmentation
AT hugginsrichardj thefateofporoushydroxyapatitegranulesusedinfacialskeletalaugmentation
AT mendelsonbryanc fateofporoushydroxyapatitegranulesusedinfacialskeletalaugmentation
AT jacobsonstever fateofporoushydroxyapatitegranulesusedinfacialskeletalaugmentation
AT lavoipierrealainm fateofporoushydroxyapatitegranulesusedinfacialskeletalaugmentation
AT hugginsrichardj fateofporoushydroxyapatitegranulesusedinfacialskeletalaugmentation